Pathways to success for this key component of Europe’s new HTA regulation, where thinking beyond the purely technical will be critical. January 2025 marked a much-anticipated milestone in the global ...

Today, the criteria used to assess the clinical value of new pharmaceuticals and medical devices varies widely across Europe, making it more challenging for biopharma companies to efficiently launch ...

Katie Rose (Consultant – Market Access), Maria Dimitrova (Consultant – HTA) and Samantha Gillard (Director – HTA) provide an overview of the EU Joint Clinical Assessment (JCA) and what it means for ...

Changes to Health Technology Assessment (HTA) in Europe offer new opportunities to streamline processes and get innovative treatments to market more quickly. However, they also require developers to ...

Relative Energy Deficiency in Sport (REDs) has various different risk factors, numerous signs and symptoms and is heavily influenced by one’s environment. Accordingly, there is no singular validated ...